Cargando…

Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women

Human papillomavirus (HPV) types 16, 18 and 58 are ranked the top three high-risk HPV types for cervical intraepithelial neoplasia (CIN) and invasive carcinoma. We aimed to evaluate the diversity of HPV16, HPV18, and HPV58 genetic variants by HPV capture technology combined with next generation sequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ying, Pan, Yaqi, Gao, Weijiao, Ke, Yang, Lu, Zheming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428204/ https://www.ncbi.nlm.nih.gov/pubmed/28325903 http://dx.doi.org/10.1038/s41598-017-00364-9

Ejemplares similares

Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology
por: Liu, Ying, et al.
Publicado: (2016)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
por: Mukherjee, Amrita, et al.
Publicado: (2023)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan
por: Onuki, Mamiko, et al.
Publicado: (2020)

Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer
por: Kogure, Gota, et al.
Publicado: (2023)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer
por: Tenjimbayashi, Yuri, et al.
Publicado: (2017)

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan
por: Tanaka, Kohsei, et al.
Publicado: (2022)

Distribution of Human Papillomavirus 52 and 58 Genotypes, and Their Expression of p16 and p53 in Cervical Neoplasia
por: Kim, Tae Eun, et al.
Publicado: (2014)

The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2017)

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
por: Castle, Philip E, et al.
Publicado: (2009)

Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity
por: Kudo, Risa, et al.
Publicado: (2022)

Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions
por: Shukla, Shirish, et al.
Publicado: (2019)

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
por: Zhang, Donghong, et al.
Publicado: (2010)

Antibodies to Human Papillomavirus 16, 18, 58, and 6b Major Capsid Proteins among Japanese Females
por: Matsumoto, Koji, et al.
Publicado: (1997)

Thermocoagulation versus cryotherapy for the treatment of cervical precancers
por: Duan, Lyufang, et al.
Publicado: (2020)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Correction: The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2018)

Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China
por: Sun, Min, et al.
Publicado: (2012)

Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer
por: Zhang, Jin-Jun, et al.
Publicado: (2018)

Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
por: Kaufman, Harvey W, et al.
Publicado: (2020)

Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria
por: Musa, Jonah, et al.
Publicado: (2023)

Sexual behavior and infection with cervical human papillomavirus types 16 and 18
por: Itarat, Yuwadee, et al.
Publicado: (2019)

Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection
por: Fujita, Misuzu, et al.
Publicado: (2022)

Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer
por: Bose, Mayilvahanan, et al.
Publicado: (2023)

Concentration of FAD as a marker for cervical precancer detection
por: Meena, Bharat L., et al.
Publicado: (2019)

Using Dynamic Features for Automatic Cervical Precancer Detection
por: Viñals, Roser, et al.
Publicado: (2021)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China
por: Fang, Liyuan, et al.
Publicado: (2020)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer
por: Van Ostade, Xaveer, et al.
Publicado: (2017)

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China
por: Yu, Lu-Lu, et al.
Publicado: (2016)

Human papillomavirus type 58: the unique role in cervical cancers in East Asia
por: Chan, Paul KS
Publicado: (2012)

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i0867kcl19qeeoetbdrmoll1b2